Ertumaxomab
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Ertumaxomab, covering 2009-05-19 to 2016-05-05. Get the full timeline:
Most recent: Clinical Trial Update: Open Label, Dose Escalating Study With Ertumaxomab In Patients With HER-2/Neu Expressing Advanced Solid Tumors [Phase 1, Phase 2]